After CEO move, GSK picks ex-Novartis exec to head consumer unit
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville/File Photo
Get Alerts GSK Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 4.8%
Revenue Growth %: +29.4%
Join SI Premium – FREE
LONDON (Reuters) - GlaxoSmithKline (NYSE: GSK) has promoted a former Novartis (NASDAQ: NOVN) executive to lead its consumer healthcare business, following the appointment last week of the unit's previous head, Emma Walmsley, as CEO designate of the drugmaker.
The British group said on Thursday that Brian McNamara, 50, who currently heads up Europe and the Americas at GSK Consumer Healthcare, would take on his new role immediately and join GSK's corporate executive team.
McNamara worked for 11 years at Novartis, where he was also in charge of consumer health, and joined GSK following the creation of a joint venture between the two companies in 2015. Prior to that he spent 16 years at Procter & Gamble (NYSE: PG).
The swift management transition will ensure the consumer business remains focused on improving financial performance and will allow Walmsley to focus on her new role as incoming CEO, a spokesman said.
She will officially take the helm at the end of March on the retirement of current CEO Andrew Witty, becoming the first woman to lead a top global drugmaker.
Separately, GSK said it had disposed of the final portion of its stake in Aspen Pharmacare
(Reporting by Ben Hirschler; Editing by Adrian Croft)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- Azerbaijani journalist remanded in latest move against independent media
- US military strategy tested as Iran-Israel warfare comes out of shadows
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!